Patheon in Supply Pact for Nasal Delivery Product
By

By
Patheon, a division of Thermo Fisher Scientific, and Evoke Pharma, a Solana Beach, California-headquartered specialty pharmaceutical company focused on treatments for gastrointestinal diseases, have signed a pact under which Patheon…

Recipharm To End Operations at Two Solid-Dosage Mfg Sites in Sweden
By

By
Recipharm plans to discontinue manufacturing operations at its solid-dose manufacturing facilities in Stockholm and Höganäs, Sweden. Since 2015, Recipharm has been implementing efficiency activities in its solid-dosage business in Sweden.…

Vetter Opens Office in South Korea
By

By
Vetter Pharma, a Ravensburg, Germany-headquartered contract development and manufacturing organization for aseptic filling and final packaging of injectables, has opened a new branch office in Songdo, South Korea. The new…

Alcami in API Supply Pact
By

By
Alcami, a contract development and manufacturing organization for active pharmaceutical ingredients (APIs) and drug products, has finalized manufacturing and quality agreements with Solasia Pharma, a Tokyo-based specialty pharmaceutical company, for…

Takeda in Pact for Needle-Free Drug Delivery
By

By
Takeda Pharmaceutical Company and Portal Instruments, a Cambridge, Massachusetts-based medical equipment manufacturer, have agreed to develop and commercialize Portal’s needle-free drug delivery device for potential use with Takeda’s investigational or…

Pfizer Amends Gene-Therapy Pact
By

By
Pfizer and Spark Therapeutics, a Philadelphia, Pennsylvania-headquartered biopharmaceutical company, have amended their license agreement for SPK-9001, an investigational gene therapy for hemophilia B. In December 2014, Pfizer signed an agreement…

EMA Finalizes Work Plan with European Health Technology Assessment Bodies
By

By
The European Medicines Agency (EMA) and the European Network for Health Technology Assessment (EUnetHTA), a network for health-technology assessment bodies across Europe, have published a joint work plan that outlines…

Novartis Partners in Gene-Editing Pact
By

By
Novartis and Homology Medicines, a Bedford, Massachusetts-based genetic medicines company focused on gene-editing and gene-therapy technology, have agreed to use Homology’s proprietary gene-editing technology to develop new treatments for select…

CSL’s Seqirus To Invest $52 Million for Flu-Vaccine Manufacturing
By

By
Seqirus, a developer and manufacturer of influenza vaccines, plans to invest £40 million ($52 million) in a new and expanded fill/finish facility at its site in Liverpool, UK for flu-vaccine…

Lupin Receives FDA Warning Letter for Dosage-Form Manufacturing Plants
By

By
Lupin, a Mumbai, India-headquartered pharmaceutical company, received a combined Warning Letter from the US Food and Drug Administration (FDA) on November 6, 2017 for two of its formulation manufacturing plants…